Chapter 5: The Briefcase
[Wakefield & Gould, Conference Room B — June 8, 2011, 9:20 AM]
Diane Kemp was five minutes early and her handshake was designed to communicate that she didn't waste time — hers or anyone else's.
"Mr. Klein. Thank you for making room in your schedule."
"Ms. Kemp." Don shook her hand and gestured toward the conference table. Coffee was already set — he'd arrived at eight to arrange the room, moving the chairs so the morning light from the window fell on his side of the table rather than hers. A small advantage. The kind of thing most people wouldn't notice consciously but would register as a vague sense that the person across from them looked more composed than they should.
Kemp sat. She was mid-forties, pragmatic haircut, a suit that cost enough to signal competence but not enough to signal vanity. VP of Legal Affairs at MediTech Solutions. The kind of corporate officer who'd risen through a pharmaceutical company by being twice as prepared as the men around her and half as loud about it.
Detection read her as tightly controlled but not deceptive. The frustration underneath was genuine — a low hum of dissatisfaction that had been building for months.
"Let me be direct," Kemp said. "We've been with Pearson Hardman for two years. Their work has been adequate. Not exceptional — adequate. Our supplier contracts come up for renegotiation this quarter and their point person has been unresponsive for three weeks."
"Three weeks is a long time in a ninety-day window," Don said.
Kemp's eyes sharpened. "You know about the clause."
"I know pharmaceutical supply contracts in this market typically carry ninety-day renegotiation triggers tied to annual performance benchmarks. Your window opened — what, April first?"
"March twenty-eighth."
"Which means you've burned through a third of your negotiating timeline waiting for a return phone call."
Kemp set her jaw. The frustration spiked in Don's detection — hotter now, personal. This wasn't just a business problem. Someone at PH had made her feel unimportant, and Diane Kemp was not a woman who tolerated being made to feel unimportant.
Martin Wakefield chose that moment to enter. He'd been watching from his office — Don had briefed him that morning, framing MediTech as a referral rather than a targeted acquisition. Wakefield trusted Don's preparation, especially after the Marsh deposition and the housing court victory. What he didn't know was how Don had identified MediTech in the first place.
"Ms. Kemp," Wakefield said, extending his hand. "Martin Wakefield. Welcome to the firm."
Pleasantries. Credentials. The dance that corporate clients expected before they felt comfortable handing over sensitive documents. Wakefield handled this part with the warm authority of a man who'd been doing it for thirty years. Don let him lead, adding specifics only when the conversation turned to contract law.
The Library hovered at low power. Don had spent the previous week feeding it everything he could find on pharmaceutical supply chain litigation — cases, regulations, DHCR rulings that intersected with commercial contracts, even a law review article on unconscionability doctrine in pharmaceutical pricing. The tags were richer now. Deeper. When Kemp mentioned her supplier's name — Haverford Chemical — the Library generated three gold strategy tags before she finished the sentence.
Don didn't chase them. Not yet. The meeting was about trust, not performance.
"Here's what I'd propose," Don said when the conversation reached the decision point. "A full review of your supplier contracts, focused on the renegotiation terms and any liability provisions that may have been overlooked. I can have preliminary findings within a week."
"A week." Kemp looked at Wakefield.
"Don's our strongest contract analyst," Wakefield said, which was true as of six weeks ago and getting truer by the day.
Kemp pulled a folder from her briefcase. Preliminary engagement letter. She'd come prepared to sign.
"One condition," she said. "I want direct access to whoever's handling my file. Not a paralegal. Not an assistant. The person doing the work."
"That would be me," Don said.
Kemp signed. Wakefield witnessed. The engagement letter joined the filing system, and MediTech Solutions officially became a Wakefield & Gould client.
---
[Wakefield & Gould, Don's Office — 6:45 PM]
The office was quiet. Most of the associates had left by six. Don sat at his desk with the MediTech engagement letter in a folder and his laptop open to the New York Law Journal's daily digest.
He wasn't reading the Journal. He was scanning it — the way he'd been scanning it every evening for two weeks, looking for one specific signal in the industry chatter.
There it was. Page three, legal personnel section:
Pearson Hardman LLP announces the promotion of Harvey R. Specter to Senior Partner, effective immediately. Specter, a graduate of Harvard Law School, joins the firm's senior partnership as the youngest attorney to achieve the rank in the firm's history.
Don leaned back.
Somewhere across Manhattan — in a hotel conference room that smelled like carpet cleaner and corporate ambition — Harvey Specter had just finished interviewing candidates for his new associate position. And somewhere else, probably running down a corridor with a briefcase full of marijuana, a college dropout with a photographic memory had stumbled into the interview of his life.
Mike Ross. The secret that would crack Pearson Hardman's foundation and reshape Manhattan's legal landscape for the next eight years. The fraud who was also the best natural legal mind in the city. The kid who'd memorize a case file in a single reading and argue circles around attorneys with twenty years of experience, and who'd do it all while living in terror that someone would ask to see his Harvard diploma.
Don closed the laptop.
The detection was quiet — no one in the room to lie to him, no ambient deception to filter. Just the hum of the building's ventilation and the distant sound of a vacuum cleaner on the floor below.
He opened the lower desk drawer. The Glenfiddich bottle sat where he'd stashed it three weeks ago — his private supply, kept for moments that felt like milestones. He poured two fingers into a paper cup, because Wakefield & Gould's junior associates didn't rate glass tumblers.
"First client I picked," Don said to the empty room. "Not inherited. Not assigned. Mine."
He drank. The scotch burned. The paper cup softened against his fingers.
MediTech was real. A real company with real problems and a real VP who'd signed a real engagement letter because Don had offered a real solution. Not because of meta-knowledge or Library tricks or absorption espionage — those tools had led him to the opportunity, but closing the deal had required actual legal competence. Actual preparation. Actual conversation with an actual human being who'd looked him in the eyes and decided to trust him.
That distinction mattered.
The paper cup was empty. Don crushed it, dropped it in the wastebasket, and stared out his window. The Pearson Hardman building was visible from this angle — a sliver of glass between two older structures, its upper floors catching the last orange light of a June evening.
Inside those walls, a secret had just walked through the door. Cheap suit. Someone else's résumé. An eidetic memory and the desperate hope that nobody would look too closely.
Don watched the building until the light faded and the glass turned into mirrors reflecting the city back at itself.
Then he pulled the MediTech file toward him and opened it. The contract documents were thick — three supplier agreements, two amendments, a licensing side letter, and a stack of correspondence that PH's junior team had generated over eight months of mediocre stewardship.
The Library stirred. Tags began forming at the periphery of his vision, faint and preliminary. Blue subject tags. A flicker of red — something the Library wanted to flag but couldn't yet resolve without deeper analysis.
Don made a note: Red tag on Haverford Chemical supplier agreement. Section TBD. Follow up tomorrow.
He closed the file and stood. His back ached from nine hours in a desk chair. His eyes were dry from scanning documents. Normal human complaints — no supernatural cost, just the price of working late in a body that needed sleep and rarely got enough.
The MediTech contract file sat on his desk, its red-flagged secret waiting. Across the city, Mike Ross was probably sitting in Harvey Specter's office right now, trying to look like he belonged. Two secrets in two buildings, each one a loaded weapon pointed at its owner's career.
Don turned off the desk lamp. Picked up his jacket.
The elevator took him to the lobby. The night security guard nodded. The street was warm for June — Manhattan storing the day's heat in its concrete and releasing it slowly, like a body cooling after a fever.
Don walked south toward the Village. The MediTech file would keep until morning. The red tag would be there when he came back. And somewhere in Midtown, Harvey Specter was betting his career on a kid who'd never set foot in a law school classroom.
Good luck, Don thought, and meant it for both of them.
Author's Note / Promotion:
Your Reviews and Power Stones are the best way to show support. They help me know what you're enjoying and bring in new readers!
You don't have to. Get instant access to more content by supporting me on Patreon. I have three options so you can pick how far ahead you want to be:
🪙 Silver Tier ($6): Read 10 chapters ahead of the public site.
👑 Gold Tier ($9): Get 15-20 chapters ahead of the public site.
💎 Platinum Tier ($15): The ultimate experience. Get new chapters the second I finish them . No waiting for weekly drops, just pure, instant access.
Your support helps me write more .
👉 Find it all at patreon.com/fanficwriter1